H1B Salary Data

Home › Employers › AllCare Plus Pharmacy Inc.

AllCare Plus Pharmacy Inc.: H-1B salaries and sponsorship

AllCare Plus Pharmacy Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $121,000.

Applications (LCAs)3
Certified3
Employer addressDurham, NC
H-1B dependent employerNo
Median offered salary$121,000
Middle half of salaries$97,985–$128,000
10th–90th percentile$84,176–$132,200

Does AllCare Plus Pharmacy Inc. sponsor H-1B visas?

AllCare Plus Pharmacy Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 5, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Cloud Engineer 11$74,970
Senior Software Development Engineer1$121,000
Senior Database Management Specialist1$135,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$97,985
FY20241$135,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Senior Database Management Specialist$135,000–$157,000
Level III
Forney, TXMar 5, 2024Mar 11, 2024Certified
Senior Software Development Engineer$121,000–$174,000
Level II
Northborough, MAApr 26, 2023Oct 1, 2023Certified
Cloud Engineer 1$74,970–$100,000Waltham, MAFeb 14, 2023Aug 15, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).